School of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA.
Division of Gerontology, Department of Medicine, Geriatrics, Palliative Care, University of Alabama at Birmingham, Birmingham, AL, USA.
J Palliat Care. 2023 Jan;38(1):52-61. doi: 10.1177/0825859720975978. Epub 2020 Dec 1.
Palliative care trial recruitment of African Americans (AAs) is a formidable research challenge.
Examine AA clinical trial recruitment and enrollment in a palliative care randomized controlled trial (RCT) for heart failure (HF) patients and compare patient baseline characteristics to other HF palliative care RCTs.
This is a descriptive analysis the ENABLE CHF-PC (Educate, Nurture, Advise, Before Life Ends: Comprehensive Heartcare for Patients and Caregivers) RCT using bivariate statistics to compare racial and patient characteristics and differences through recruitment stages. We then compared the baseline sample characteristics among three palliative HF trials.
Of 785 patients screened, 566 eligible patients with NYHA classification III-IV were approached; 461 were enrolled and 415 randomized (AA = 226). African Americans were more likely to consent than Caucasians (55%; = .001), were younger (62.7 8; = .03), had a lower ejection fraction (39.1 15.4; = .03), were more likely to be single ( = .001), and lack an advanced directive (16.4%; < .001). AAs reported higher goal setting (3.3 1.3; = .007), care coordination (2.8 1.3; = .001) and used more "denial" coping strategies (0.8 1; = .001). Compared to two recent HF RCTs, the ENABLE CHF-PC sample had a higher proportion of AAs and higher baseline KCCQ clinical summary scores.
ENABLE CHF-PC has the highest reported recruitment rate and proportion of AAs in a palliative clinical trial to date. Community-based recruitment partnerships, recruiter training, ongoing communication with recruiters and clinician co-investigators, and recruiter racial concordance likely contributed to successful recruitment of AAs. These important insights provide guidance for design of future HF palliative RCTs.
ClinicalTrials.gov Identifier: NCT02505425.
在招募非裔美国人(African Americans,AAs)参与姑息治疗试验方面,存在着艰巨的研究挑战。
本研究旨在评估在一项针对心力衰竭(heart failure,HF)患者的姑息治疗随机对照试验(randomized controlled trial,RCT)中 AAs 的临床试验招募和入组情况,并与其他 HF 姑息治疗 RCT 中的患者基线特征进行比较。
本研究对 ENABLE CHF-PC(Educate,Nurture,Advise,Before Life Ends:Comprehensive Heartcare for Patients and Caregivers)RCT 进行了描述性分析,使用双变量统计比较了不同招募阶段的种族和患者特征及差异。我们还比较了三项姑息性 HF 试验的基线样本特征。
在对 785 名患者进行筛查后,对 566 名符合 NYHA 分级 III-IV 级的合格患者进行了评估;其中 461 名患者同意入组,415 名患者完成随机分组(AAs 组 226 名)。与白人患者相比,AAs 更有可能同意入组(55%; =.001),且更年轻(62.7 8; =.03),左心室射血分数更低(39.1 15.4; =.03),更有可能单身( =.001),缺乏高级指令(16.4%; <.001)。AAs 组患者的目标设定得分更高(3.3 1.3; =.007),护理协调得分更高(2.8 1.3; =.001),使用“否认”应对策略的比例更高(0.8 1; =.001)。与两项近期的 HF RCT 相比,ENABLE CHF-PC 样本中的 AAs 比例更高,基线 KCCQ 临床综合评分也更高。
在迄今为止开展的姑息治疗临床试验中,ENABLE CHF-PC 的招募率和 AAs 比例均为最高。社区为基础的招募伙伴关系、招募人员培训、与招募人员和临床共同研究者的持续沟通,以及招募人员的种族一致性,可能促成了 AAs 的成功招募。这些重要的经验为未来 HF 姑息治疗 RCT 的设计提供了指导。
ClinicalTrials.gov 标识符:NCT02505425。